Intelligent Bio Solutions Inc. announced the successful completion of a key development milestone in its plans to add ketamine and tramadol to its Intelligent Fingerprinting Drug Screening System. New assays for testing both drugs have passed the Company?s initial design phase and are ready for scale-up and transfer to manufacture in preparation for potential clinical trials. After completing these activities and successful clinical trials, the assays can be added to the panel of substances detected by the Company?s proprietary drug screening system.

Ketamine is widely recognized worldwide as having the potential for drug abuse due to its hallucinogenic properties, while the synthetic opioid pain reliever tramadol is being added to controlled substances lists around the world. The Intelligent Fingerprinting Drug Screening System is portable and works by analyzing fingerprint sweat. It is non-invasive, fast, and cost-effective, with sample collection taking seconds and simultaneous screening for multiple drug groups in ten minutes.

A laboratory confirmation service is also available. The system has applications within many sectors, and customers include employers in safety-critical industries such as construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.